TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/1/26 18:34 | 6/29/26 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Epperly Melissa B, | D | M.d | 79 | 4.46 | 0 | 18 | 16 | D | |||||||||||||||||
7/1/26 18:34 | 6/29/26 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Epperly Melissa B, | D | S.d | -610 | 34.38 | 0 | -18 | -52 | 16 | D | ||||||||||||||||
2/12/24 20:22 | 2/12/24 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Epperly Melissa B, | NY | O | CFO | S | -29 | 11.44 | 0 | -3 | -1 | 451 | D | |||||||||||||||
2/5/24 19:12 | 2/2/24 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Epperly Melissa B, | NY | O | CFO | S.d | -100 | 11.54 | 0 | -9 | -2 | 454 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |